Medical staff preparing for vaccination with confidence▶ Click here for a larger view
The quarantine authorities expressed their position that they would make a decision after sufficiently analyzing each country’s vaccination results regarding whether or not to expand the targets for vaccination against AstraZeneca (AZ)’s novel coronavirus infection (Corona 19).
Accordingly, it is noteworthy whether over 65 years of age, who were excluded from priority vaccination due to the controversy about the effect of vaccination for the elderly, will get this vaccine.
In an online briefing on the 2nd, Jung Kyung-sil, head of the vaccination management team of the Corona 19 Vaccination Response Promotion Team, said, “We are constantly collecting relevant evidence” on whether or not the elderly 65 years of age or older have received the AstraZeneca vaccine. “After analyzing this and accumulating evidence, It will be decided after receiving expert advice and deliberation by the Vaccination Specialist Committee.”
Regarding the specific timing of the decision, he said, “We are not reviewing the data by limiting the specific time period,” he said. “I think that if the data such as thesis and clinical trial results are accumulated enough, we can judge it at any time.”
In the first quarter, the government was planning to inoculate the AstraZeneca vaccine to all hospitalized, residents, and workers in nursing homes and hospitals in the first quarter, but the vaccination was withheld for those over 65 years of age.
This is in accordance with the recommendation of the Ministry of Food and Drug Safety to carefully decide on the use of the AstraZeneca vaccine for those over 65 years of age. The Ministry of Food and Drug Safety at the time proved the safety and effectiveness of the AstraZeneca vaccine, but made this decision because of the lack of clinical studies in the elderly.
In this situation, a recent study in the UK has shown that the AstraZeneca vaccine is also effective for the elderly.
The UK’s England Public Health Administration (PHE) surveyed elderly people aged 80 and older who received this vaccine once, and found that hospitalization after 3-4 weeks decreased by 80%, and in those aged 70 and older, the effect of preventing infection after 4 weeks of vaccination was 60. It was counted as ∼73%.
France acknowledged the effectiveness of the vaccine and extended the vaccination age to 74, and Germany is known to reconsider its policy of “not recommending AstraZeneca vaccination to the elderly”.
“Clinical trials are currently in progress in each country, and in some countries, vaccination results for the elderly are coming out,” said Mr. Jeong. “Not only the results of the US clinical trial, but also the results of each country’s vaccination are reported as a whole. ) I will decide.”
Currently, from the 26th of last month in Korea, among the inpatients, residents, and workers of nursing homes and nursing hospitals, under 65 years of age will receive the AstraZeneca vaccine, and from the 27th, the medical staff and workers of the Corona 19 patient treatment hospital and life treatment center will be Pfizer. I am getting the vaccine.
Securing half of the nation’s overseas vaccines… Are there any disruptions to the vaccination schedule? (CG)▶ Click here for a larger view
On the other hand, the government knows who will be vaccinated every month and delivers the required amount of vaccine to each institution, but it is known that it is proceeding without any problems until now. When the monthly vaccination target is confirmed, the government gives access to the’subject registration system’ to the facilities where they are located, and requires each institution to enter the target person.
Regarding this, he said, “up to now, we are proceeding as planned without any delay,” but said, “However, there may be cases in which the registration of target subjects is partially delayed due to so many institutions.”
“There is currently no report that the establishment of the center is delayed due to this problem.” “We are going to install the center, but now we are paying rent through the national treasury, so we will be able to cover the cost of installing the center.”
There are currently 5 vaccination centers for vaccinating mRNA (messenger ribonucleic acid) vaccines such as Pfizer, one central vaccination center, three regional centers, and one regional center. do.
[연합뉴스]
Copyrights ⓒ Yonhap News. Unauthorized reproduction and redistribution prohibited